--- title: "Tonghua Dongbao Pharmaceutical Co.,Ltd. (600867.SH) — 公司概況" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/600867.SH/overview.md" symbol: "600867.SH" name: "Tonghua Dongbao Pharmaceutical Co.,Ltd." parent: "https://longbridge.com/zh-HK/quote/600867.SH.md" datetime: "2026-04-04T16:05:16.082Z" locales: - [en](https://longbridge.com/en/quote/600867.SH/overview.md) - [zh-CN](https://longbridge.com/zh-CN/quote/600867.SH/overview.md) - [zh-HK](https://longbridge.com/zh-HK/quote/600867.SH/overview.md) --- > 支持的語言: [English](https://longbridge.com/en/quote/600867.SH/overview.md) | [简体中文](https://longbridge.com/zh-CN/quote/600867.SH/overview.md) # Tonghua Dongbao Pharmaceutical Co.,Ltd. (600867.SH) — 公司概況 ## 基本資訊 | 項目 | 詳情 | |------|--------| | 行業 | Pharmaceuticals | | 交易所 | CN Market | | 地址 | Dongbao New Village, Tonghua County, Jilin Province | | 官網 | [www.thdb.com](https://www.thdb.com) | ## 公司簡介 Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. ## 核心管理層 | 名稱 | 職位 | |------|-------| | 李佳鸿 | 董事长 & 总经理 & 代理董事会秘书 | | 范朴 | 副总裁 | | 张国栋 | 副总经理 | | 张文海 | 副总经理 | | 关东亮 | 副总裁 | | 迟军玉 | 总会计师 | | 谷丽萍 | 证券事务代表 | ## 業務構成 | 業務線 | 營收 | 佔比 | |---------|---------|-------| | Pharmaceutical Industry | 1973675460 | 99.86% | | Real Estate Industry | 2690190 | 0.14% | ```vega-lite { "$schema": "https://vega.github.io/schema/vega-lite/v5.json", "title": "Tonghua Dongbao Pharmaceutical Co.,Ltd. Business Breakdown", "data": { "values": [ { "segment": "Pharmaceutical Industry", "ratio": 99.86 }, { "segment": "Real Estate Industry", "ratio": 0.14 } ] }, "mark": "arc", "encoding": { "theta": { "field": "ratio", "type": "quantitative" }, "color": { "field": "segment", "type": "nominal" } } } ``` ## 地區分佈 | 地區 | 營收 | 佔比 | |--------|---------|-------| | China | 1873352264 | 94.79% | | Foreign | 103013386 | 5.21% | --- > **免責聲明: 本文僅供參考,不構成任何投資建議。**